as on November 15, 2025 at 2:29 am IST
Day's Low
Day's High
1.35%
Downside
1.68%
Upside
52 Week's Low
52 Week's High
56.33%
Downside
6.23%
Upside
Check Castle Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$996.5M
EPS (TTM)
-0.8957
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.52%
PE Ratio (TTM)
-265.38
Industry PE ratio
-0.8126129032258065
PEG Ratio
0EBITDA
7.8M
Revenue (TTM)
343.5M
Profit Margin
-3.56%
Return On Equity TTM
-2.70%
Track how Castle Biosciences Inc P/E has moved over time to understand its valuation trends.
Castle Biosciences Inc in the last 5 years
Lowest (-159.17x)
June 30, 2024
Today (-265.38x)
November 17, 2025
Industry (-0.81x)
November 17, 2025
Highest (127.26x)
September 30, 2024
Today’s Price to Earnings Ratio: -265.38x
Compare market cap, revenue, PE, and other key metrics of Castle Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $996.5M | -30.49% | -265.38 | -3.56% | |
| BUY | $56.0B | 51.35% | 54.63 | 24.65% | |
| BUY | $218.0B | 20.82% | 33.45 | 15.02% | |
| BUY | $38.1B | 28.11% | 30.3 | 8.07% | |
| BUY | $41.6B | 33.64% | 34.22 | 17.97% |
The Castle Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Castle Biosciences Inc investment value today
Current value as on today
₹1,24,139
Returns
₹24,139
(+24.14%)
Returns from Castle Biosciences Inc Stock
₹18,897 (+18.9%)
Dollar Returns*
₹5,242 (+5.24%)
Based on 15 analysts
93.33%
Buy
6.67%
Hold
0.00%
Sell
Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Castle Biosciences Inc. Average target price of $37.25
Get share price movements and forecasts by analysts on Castle Biosciences Inc.
What analysts predicted
10.31%UPSIDE
Target Price
$37.25
Current Price
$33.41
Analyzed by
15 Analysts
Target
$37.25
Castle Biosciences Inc target price $37.25, a slight upside of 10.31% compared to current price of $33.41. According to 15 analysts rating.
Search interest for Castle Biosciences Inc Stock has increased by 783% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:783% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, CSTL stock has moved up by 51.1%
Against Peers
![]()
In the last 3 years, Idexx Laboratories, Inc. has given 68.1% return, outperforming this stock by 0.8%
Against Peers
![]()
In the last 1 year, Idexx Laboratories, Inc. has given 63.9% return, outperforming this stock by 44.9%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 4.52M → -501.0K (in $), with an average decrease of 111.1% per quarter
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 87.98M → 83.04M (in $), with an average decrease of 2.9% per quarter
| Organisation | Castle Biosciences Inc |
| Headquarters | 505 S. Friendswood Drive, Friendswood, TX, United States, 77546 |
| Industry | Health Technology |
| CEO | Mr. Derek J. Maetzold |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Kevin Doman | Vice President of Sales |
Mr. Derek J. Maetzold | Founder, CEO, President & Director |
Mr. Tobin W. Juvenal | Chief Commercial Officer |
Ms. Camilla Zuckero | Vice President of Investor Relations & Corporate Affairs |
Ms. Keli Greenberg | Vice President of Human Resources |
Dr. Matthew Goldberg M.D. | Senior Vice President of Medical |
Mr. Frank Stokes | CFO & Treasurer |
Ms. Kristen M. Oelschlager R.N. | Chief Operating Officer |
Dr. Jay Braxton Pharm.D. | VP of Marketing & Brand Manager of Uveal Melanoma (UM) |
Castle Biosciences Inc share price today is $33.41 as on at the close of the market. Castle Biosciences Inc share today touched a day high of $33.97 and a low of $32.96.
Castle Biosciences Inc share touched a 52 week high of $35.49 on and a 52 week low of $14.59 on . Castle Biosciences Inc stock price today i.e. is closed at $33.41,which is 5.86% down from its 52 week high and 128.99% up from its 52 week low.
Castle Biosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Castle Biosciences Inc (CSTL) shares with as little as ₹88.74 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.40 in Castle Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Castle Biosciences Inc share’s latest price of $33.41 as on November 15, 2025 at 2:29 am IST, you will get 0.2993 shares of Castle Biosciences Inc. Learn more about
fractional shares .
Castle Biosciences Inc stock has given -30.49% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?